<DOC>
	<DOC>NCT02092818</DOC>
	<brief_summary>In accordance with the regulatory guidance this registry has been designed to collect information about the long-term safety of Adempas in real clinical practice outside the regulated environment of a controlled clinical study.</brief_summary>
	<brief_title>EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<criteria>Female and male patients who start or are on treatment with Adempas Written informed consent Patients currently participating in an interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>